High consumption of fish oil may benefit cardiovascular health
Eating fish in amounts comparable to
those of people living in Japan seems to impart a protective factor that wards
off heart disease, according to an international study funded by the National
Institutes of Health (NIH) and led by the University of Pittsburgh Graduate
School of Public Health.
Middle-aged Japanese men living in
Japan had lower incidence of coronary artery calcification, a predictor of
heart disease, than middle-aged white men living in the United States, likely
due to the significantly higher consumption of omega-3 fatty acids found in
fish. The findings will be published in the March 6, 2014 issue of the journal Heart.
"Multiple studies have looked at
the effect of fish oil on cardiovascular health, with mixed results," said
lead author Akira Sekikawa, M.D., Ph.D., associate professor of epidemiology at
Pitt Public Health. "Previous studies investigated substantially lower
intake of omega-3 fatty acids than what people in Japan actually get through
their diet. Our study seems to indicate that the level of marine-derived
omega-3 fatty acids consumed must be higher than previously thought to impart
substantial protection."
Marine-derived omega-3 fatty acids,
which are found in fish, especially oily fish, as well as in squid and krill,
may help to reduce inflammation and slow the formation of fatty plaques in
arteries.
Researchers at Pitt partnered with
scientists in Japan, Hawaii and Philadelphia to follow nearly 300 men for five
years, tracking multiple factors that affect cardiovascular health, including
cigarette smoking, the level of cholesterol in the blood and alcohol
consumption, as well as their rates of diabetes and high blood pressure.
After accounting for risk factors
for heart disease, the U.S. men had three times the incidence of coronary
artery calcification as the Japanese men. Meanwhile, the levels of
marine-derived omega-3 fatty acid in the blood were more than 100 percent
higher in the Japanese than in the white men.
"The vast difference in heart
disease and levels of marine-derived omega-3 fatty acid are not due to genetic
factors," said Dr. Sekikawa. "When we look at Japanese Americans, we
find that their levels of coronary artery calcification are actually higher
than that of the rest of the U.S. population."
The average dietary intake of fish
by Japanese people living in Japan is nearly 100 grams each day, which the
American Heart Association considers 1 ½ servings. The average American eats
about 7 to 13 grams of fish a day, or about one serving a week.
Heart disease is the leading cause
of death in the U.S. and globally, according to the World Health Organization.
However, Japan bucks this trend, with cancer as the leading cause of death.
"I am not encouraging Americans
to start consuming massive amounts of fish, which may have harmful
contaminants, such as mercury, in their flesh," said Dr. Sekikawa.
"However, our findings indicate that it is worthwhile to take another look
at the effect of marine-derived omega-3 fatty acids on heart disease,
particularly when consumed at higher rates than previously investigated."
Fish oil
supplements may protect the heart in stressful situations
Fish
oil may help the heart beat mental stress
The
omega 3 fatty acids in fish oil have long been thought to protect against
cardiovascular disease—so much so that the American Heart Association currently
recommends eating at least two servings of fish a week, particularly fatty
varieties rich in omega 3s. However, the mechanism behind this protective
effect still remains a mystery.
In
a new study, scientists led by Jason R. Carter of Michigan Technological
University shed light on this phenomenon by providing evidence that fish oil
might specifically counteract the detrimental effects of mental stress on the
heart. Their findings show that volunteers who took fish oil supplements for
several weeks had a blunted response to mental stress in several measurements
of cardiovascular health, including heart rate and muscle sympathetic nerve
activity (MSNA), part of the "fight or flight" response, compared to
volunteers who took olive oil instead. The results may explain why taking fish
oil could be beneficial to the heart and might eventually help doctors prevent
heart disease in select populations.
The
article is entitled "Fish Oil and Neurovascular Reactivity to Mental
Stress in Humans." It appears in the May, 2013 edition of the American Journal of Physiology – Regulatory,
Integrative, and Comparative Physiology, published by the American
Physiological Society.
Methodology
Carter
and his colleagues worked with 67 adult volunteers. At the beginning of the
study, each volunteer underwent a battery of tests to assess cardiovascular
function, including heart rate, blood pressure, MSNA, and blood flow through
the forearm and calf. These tests were performed first when the volunteers were
at rest, and then again while they were performing a mental arithmetic test
while the investigator encouraged them to hurry, a situation designed to induce
acute mental stress. The study subjects were then nearly equally assigned to
take either 9 grams of fish oil per day or 9 grams of olive oil, a placebo that
hasn't been shown to have the same beneficial cardiovascular effects as fish
oil. None of the volunteers were aware of which supplement they were taking.
After 8 weeks of this intervention, the study subjects underwent the same tests
again.
Results
The
researchers found that test results didn't change between the two groups of
study subjects when they were at rest. However, results for the volunteers who
took fish oil and those who received the placebo differed significantly for
some of the tests during the mental stress. Those in the fish oil group showed
blunted heart rate reactivity while they were stressed compared to those who
took olive oil. Similarly, the total MSNA reactivity to mental stress was also
blunted in the fish oil group.
Importance
of the Findings
These
results show that fish oil could have a protective effect on cardiovascular
function during mental stress, a finding that adds a piece to the puzzle on why
taking fish oil helps the heart stay healthy, the authors suggest. Future
studies might focus on the effects of taking fish oil for longer time periods
and examining this effect on older populations or people with cardiovascular
disease.
"Overall,"
the study authors say, "the data support and extend the growing evidence
that fish oil may have positive health benefits regarding neural cardiovascular
control in humans and suggest important physiological interactions between fish
oil and psychological stress that may contribute to disease etiology."
Omega-3 fatty acids appear to protect damaged heart after heart attack
Taking omega-3 fatty acids appeared
to lower inflammation and guard against further declines in heart function
among recent heart attack survivors already receiving optimal standard care,
according to results from a randomized, controlled trial presented at the
American College of Cardiology's 64th Annual Scientific Session in San Diego (2015).
Patients in the study taking 4 grams
of prescription-only omega-3 fatty acid capsules daily for six months after a
heart attack were significantly more likely to show improvements in heart
function compared to patients taking a placebo. Heart function was measured by
an expansion of the left ventricular endsystolic volume index. Patients taking
omega-3 fatty acids also had significantly less evidence of fibrosis -- a
thickening or scarring of the areas of the heart remote from the heart attack,
which can develop when the surviving heart muscle works harder and under high
pressure to compensate for the damage to the heart. The data suggests that
patients who were able to mount a substantial change in levels of omega-3 fatty
acids in their blood derived the most benefit.
"Giving a high dose of omega-3
fatty acids soon after a heart attack appears to improve cardiac structure and
heart functioning above and beyond the standard of care," said Raymond W.
Kwong, M.D., M.P.H, director of cardiac magnetic resonance imaging at Brigham
and Women's Hospital in Boston and the study's senior author. "Because
this is a unique group of patients with remarkably high adherence to
[guideline-directed] treatments for acute myocardial infarction already, we
feel fairly confident that the benefits from this therapy are additive. The
implications of this study could be fairly large."
An estimated 720,000 Americans have
heart attacks each year. After a heart attack, the heart can remodel or
reorganize itself to maintain or improve function. In some cases, the heart may
undergo adverse changes such as enlargement of the heart, decreased pumping
ability or added cardiac strain that can predispose someone to heart failure
and arrhythmias later in life.
Although earlier studies have shown
that omega-3 fatty acids may lower the risk of irregular heartbeats and death
from a heart attack, research has not consistently shown a benefit. Kwong said
his research is the first to use quantitative cardiac imaging to look at how
omega-3 fatty acids might actually protect the heart after a major heart
attack.
Researchers randomized 374 patients
recovering from a heart attack and receiving standard treatment to take either
4 grams of omega-3 fatty acids or a placebo; groups were balanced in terms of
location of the infarct--anterior or non-anterior--and age. Blood work and
cardiac imaging were analyzed at two to four weeks post-heart attack and again
at six months. Compared to previous research, this study used a much higher
dose of omega-3 fatty acids, 4 grams compared to 1 gram daily, and a small
amount of corn oil, which does not contain fatty acids, as the placebo.
By using cardiac magnetic resonance
imaging, researchers were able to look at changes in patients' hearts and see
the disease process before and after treatment. Adverse changes in left
ventricular remodeling and function, in addition to the worsening of fibrosis,
were used as surrogates for poor outcomes after heart attack.
Patients taking the omega-3 fatty
acids were 39 percent less likely to show a deterioration of heart function as
compared to patients taking a placebo. The analysis also looked at key markers
of systemic inflammation, which were also more likely to be improved in those
taking the fish oil. In particular, the percent reduction in ST2, a marker of
the severity of adverse cardiac remodeling and tissue fibrosis, was
substantially greater in the treatment arm after six months.
"Omega-3 fatty acids may have
anti-inflammatory effects and also promote better cardiac healing," Kwong
said. "This is important because other anti-inflammatory agents, including
steroids and NSAIDS, have failed to make a difference after myocardial
infarction." Patients in the study who had a 5 percent increase in the
amount of omega-3 fatty acid in their blood seem to have the best chance of
improving heart function.
"If this becomes a useful
therapy, it seems a 5 percent increase in the serum level of omega-3 fatty
acids correlates with a 10 percent improvement in left ventricular
remodeling," he said. In this study, most (92 percent) of patients
randomized to fish oil increased omega-3 fatty acid by at least 5 percent,
compared with less than half (42 percent) of patients receiving placebo.
Kwong said the higher-dose omega-3
fatty acids was not found to be associated with any major safety issues, such
as increased bleeding. "It's a very well-tolerated therapy," he said,
adding that it is unlikely patients could get the amount of omega-3 fatty acids
from diet alone. He said the daily 4 gram dose is roughly equivalent to someone
eating a large, 8-ounce serving of salmon every day for six months.
For many years, the American College
of Cardiology and the American Heart Association have recommended that people
eat fish rich in omega-3 fatty acids at least twice a week because of its
potential heart benefits.
Kwong said most North Americans do
not follow this advice, while Japanese populations with higher levels of
omega-3 and an otherwise similar risk profile to North Americans have lower
risks of heart disease and sudden cardiac death. The increase in the omega-3 blood
content of many patients in Kwong's study at six months was similar to levels
found in Japanese populations with a diet very rich in omega-3 fatty acids.
Fatty fish such as salmon, tuna, trout and sardines
contain the most omega-3 fatty acids. Fatty acids are a key component of cell
membranes and they help with cell signaling, proper immune function and may
also improve cognitive functioning. This study is limited in that it did not
investigate the association between omega-3 fatty acids and cardiac events
after heart attack; assessing this relationship would require a large group of
patients over many years. It also did not evaluate this treatment immediately
after having a heart attack.
A fish a day
keeps the doctor away
Most
people, whether healthy or having cardiovascular disease (CVD), would benefit
from regular consumption of oily fish, concluded speakers at the EuroPRevent
2012 meeting. While eating whole fish undoubtedly offers the optimum approach
for increasing omega-3 intakes in both primary and secondary prevention, delegates
heard, supplements have a major role to play in increasing omega-3 intakes for
people who do not like fish. The EuroPRevent 2012 meeting, held 3 May to 5 May
2012 in Dublin, Ireland, was organised by the European Association for
Cardiovascular Prevention and Rehabilitation (EACPR), a registered branch of
the European Society of Cardiology (ESC).
The
symposium " A fish a day keeps the doctor away" (1) centred on the
cardiovascular disease (CVD) benefits of the long chain highly unsaturated
omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)
found in the flesh of oily fish, such as salmon, mackerel, herring, trout and
sardines. In the round table debate speakers attempted to unravel the current
confusion where initial studies showed eating fish/taking omega 3 supplements
delivered CVD benefits, but more recent studies with supplements failed to
reproduce these effects.
"Omega-3
fatty acids are really important to human health, whether you're talking about
CVD, brain or immune health. Heath professionals have a key role to play in
educating the public about the beneficial effects of including fish in their
diets," said Philip Calder, a metabolic biochemist and nutritionist from
the University of Southampton, UK.
The
latest European Guidelines on Cardiovascular Disease Prevention in Clinical
Practice, also launched at the EuroPRevent 2012 meeting, recommend that people
should eat fish at least twice a week, one meal of which should be oily fish
(2). For people opting for supplements, warned Calder, it is best to take
pharmaceutical grade preparations of omega-3 oils since not all over the
counter preparations contain the same dose of the fatty acids. "It's
important that health professionals give clear guidance around the need for patients
to take 1g of omega-3 a day to achieve any beneficial effects.
With
over the counter brands containing different concentrations there's a danger
people may not be receiving sufficient intakes," said Calder.
Eating
oily fish may prove more beneficial than taking capsules of omega-3. "This
is because fish contain all sorts of other nutrients like vitamin D, selenium
and iodine that may also be beneficial against CVD. And we don't have the final
proof that the benefits from eating fish come from the omega-3," said Daan
Kromhout, from Wageningen University, The Netherlands. "Fish, it needs to
be remembered, don't provide a total panacea against CVD. As well as consuming
fish, people need to eat healthy diets, not smoke and be physically active."
Conflicting
trials of omega-3
The
first association between omega-3 consumption and incidence of CVD was found in
epidemiological studies in the late 1970s when Danish investigators Bang and
Dyerberg discovered the incidence of myocardial infarction (MI) was ten times
higher among the Danish population than Greenland Inuits. "At the time the
Greenland Inuits ate diets of whale and seal meat that were exceptionally high
in omega-3 fatty acids," said Erik Berg Schmidt, from Aalborg University
Hospital, Aarhus, Denmark. "The findings went contrary to the dogma of the
time that animal fats were harmful and led to the hypothesis that omega-3 fatty
acids reduce vascular disease."
Omega-3
fatty acids are a family of naturally occurring polyunsaturated fatty acids named
according to the position of the double bonds within their hydrocarbon chain.
Since mammals lack enzymes to insert the double bond in the omega-6 or omega-3
position, they need to obtain these fatty acids from their diets. EPA and DHA
enter the food chain through marine phytoplankton and pass through fish.
The
initial trials showing a benefit for omega-3 in the secondary prevention of
patients with established CVD were:
The
Diet and Reinfarction Trial (DART), 1989, in 2,033 men who had suffered an MI showed
a 29% reduction in all-cause mortality among those who received advice to add
two fatty fish meals per week (300 g of oily fish) or to take fish oil capsules
providing an equivalent intake of marine omega-3 (3).
The
Gruppo Italiano per lo Studio della Sopravvienza nell'Infarto (GISSI)
Prevenzione trial, 1999, which enrolled 11,324 patients within three months of
an MI, showed that marine omega-3 fatty acids (885 mg EPA+DHA per day) lowered
the risk of the combined primary outcome of death and non-fatal cardiovascular
events by 15% (4).
The
JELIS study, 2007, which involved 18,645 Japanese patients with
hypercholesterolaemia, with or without pre-existing coronary artery disease,
showed that long-term use of 1.8 g of purified EPA daily lowered the risk of
the combined primary outcome of death and non-fatal cardiovascular events by
15% (5).
However,
in 2010, three large trials - Alpha Omega, OMEGA, and SU.FOLOM3 – all failed to
confirm the benefits of omega-3 fatty acids supplements on CVD events.
Each
of these later studies, said Berg Schmidt, had issues related to the marine
omega-3 fatty doses used, the exact mix of EPA and DHA, the lag between when
the MI occurred and initiating omega-3 fatty acid treatment, the use of newer
invasive and non-invasive strategies, the length of follow-up and sample size,
which in some cases was too small to show a beneficial effect.
Fish
intake in primary prevention
Following
the first epidemiological observations in Greenland Inuits, Kromhout told
delegates, prospective cohort studies carried out in European, American,
Japanese, and Chinese populations also showed inverse associations between fish
consumption and CVD morbidity and mortality.
Recently
a Danish cohort study from Aalborg found that when levels of omega-3 fatty
acids were measured in an adipose biopsy taken from the buttocks of 57 053
subjects, a negative dose response was found with the risk of acute MI(6).
"But there've been no trials of eating fish in healthy people because
you'd need too many participants to reach a conclusion for the trial to be
feasible," explained Kromhout.
The
only real way to look for benefits in primary prevention, he added, is to
investigate the effects on intermediate endpoints. One such study by Matthew
Pase, from the NICM Centre for Study of Natural Medicines and Neurocognition,
Melbourne, Australia, reviewing data from 10 clinical trials involving 550
participants, found omega-3 fatty acids reduced pulse wave velocity by an
average of 33 % and arterial compliance by 48 % (7).
The
mechanism of action of Omega-3 fatty acids
Omega-3
fatty acids, explained Calder, can exert a variety of actions on cell
physiology and function. "They're anti-inflammatory and might therefore
decrease the inflammatory processes within the vessel wall, which are
recognised as major contributors to atherosclerosis," he said.
Indeed,
recent studies by Calder and colleagues showed that the incorporation of EPA
into advanced plaques was associated with a decreased expression of various
matrix metalloproteinases (MMPS), proteins which have been implicated in plaque
cap thinning and increased vulnerability to rupture.
Omega-3
fatty acids are also known to have an anti-arrhythmic effect. The presence of
omega-3 fatty acids in cardiomyocyte membrane phospholipids decreases
electrical excitability and modulates the activity of ion channels (e.g.
sodium, potassium and calcium, effects that are claimed to promote electrical
stability in the cell and prevent arrhythmias. It is also known that omega-3
fatty acids are potent triglyceride lowering agents.
One
issue that has hindered studies exploring the mechanisms of action of omega-3,
added Calder, is that the amounts of EPA and DHA vary between the different
commercial preparations of omega-3. "This is important because EPA and DHA
don't always have the same actions," he said.
"With
investigators using different doses it's been hard to produce consistent
effects. To properly unravel the mechanisms we need to adopt a strategic
multidisciplinary approach where everyone uses the same dose and relative
amounts of EPA and DHA" said Calder.
References
1.
A fish a day keeps the doctor away – 14.00 to 15.30 Friday 4th May. Symposium.
Liffey Hall 1 Lecture Room
2.
European Guidelines on Cardiovascular Disease Prevention in Clinical Practice.
EHJ 2012. Doi: 10.1093/eurheartj/ehs092
3.
Burr ML, Gilbert JF, Holliday RM, et al. Effects of changes in fat, fish and
fibre intakes on death and myocardial reinfarction: diet and reinfarction trial
(DART). Lancet 1989; 344:757-61.
4.
GISSI-Prevenzione Investigators. Dietary supplementation with n-3
polyunsaturated fatty acids and vitamin E after myocardial infarction: results
of the GISSI-Prevenzione trial. Lancet 1999; 354: 447-55.
5.
Yokoyama M, Origasa H, Matsuzaki M, et al. Effects of eicosapentaenoic acid on
major coronary events in hypercholesterolaemic patients (JELIS): a randomised
open-label blinded endpoint analysis. Lancet 2007; 369:1090-98.
6.
Joensen AM, Overvad K, Dethlefsen C et al. Marine n-3 Polyunsaturated Fatty
Acids in Adipose Tissue and the Risk of Acute Coronary Syndrome. Circulation.
2011;124:1232-8
7.
Pase MP, Grima A, Sarris J, et al. Do long-chain n-3 fatty acids reduce
arterial stiffness? A meta-analysis of randomised controlled trials. British
Journal of Nutrition 2011; 106:974-80
Farmed Salmon
Raises Blood Levels of Omega-3s
People
who eat farm-raised salmon can increase their intake of beneficial omega-3
fatty acids to levels that may help reduce their risk of heart disease,
according to studies by U.S. Department of Agriculture (USDA) scientists.
The
studies by Agricultural Research Service (ARS) nutritionist Susan Raatz and
physiologist Matthew Picklo address concerns about whether farm-raised salmon
have less available omega-3s than salmon caught in the wild.
Two
omega-3 fatty acids—EPA (eicosapentaenoic acid) and DHA (docosahexaenoic
acid)—are abundant in oily fish such as salmon, tuna, mackerel, and herring.
Consuming 250 milligrams daily of EPA and DHA—the amount in a 3-ounce farmed
salmon fillet—has been associated with reduced heart disease risk.
The
scientists evaluated a group of 19 healthy human volunteers who were provided
three different portion sizes of farm-raised Atlantic salmon. Each volunteer
was assigned to consume two weekly servings of one of the three portion sizes
of salmon for a four-week period. After a "blood-clearing" break of
four to six weeks, a different portion size was served, followed by another
break. Then the third portion size was served, so that each volunteer had
tested all three portion sizes.
The
raw weights of the salmon portions fed to the volunteers were 90 grams (about
3.2 ounces), 180 grams (about 6.3 ounces), and 270 grams (about 9.5 ounces).
The Dietary Guidelines for Americans recommend consuming 8 ounces of seafood
weekly.
Blood
was collected from each of the 19 subjects to mark fatty acid levels and other
heart disease risk indicators at the beginning and end of each treatment. The
results showed that EPA blood levels doubled after the volunteers consumed the
6.3-ounce portions and increased nearly threefold after they consumed the
9.5-ounce portions. Also, based on the blood indicators, DHA levels were
elevated by about 50 percent, regardless of portion size.
Farm-raised
Salmon Retains Healthy Omega-3s When Baked
U.S.
Department of Agriculture (USDA) nutritionist Susan Raatz, physiologist Matthew
Picklo, and cooperators have found that farm-raised Atlantic salmon maintains
its healthy levels of omega-3 fatty acids when baked.
While
eating seafood rich in omega-3 fatty acids is known to reduce risk of heart
disease, it has not been known whether baking causes loss of omega-3s in
farm-raised Atlantic salmon. The team also examined the extent to which baking
Atlantic salmon alters healthful fatty acids through oxidation that leaves
unhealthy compounds, such as toxic omega-3 oxidation byproducts.
The
researchers demonstrated that baking salmon to the proper temperature does not
decrease its content of beneficial omega-3 fatty acids. They found that baking
actually decreases the presence of fatty acid oxidation byproducts. Preparing
the fish based on restaurant and safety guidelines—to a tender-but-safe 145
degrees Fahrenheit rather than overcooking—was a key factor, according to
authors.
This
research was published in the Journal of
the Academy of Nutrition and Dietetics.
Fish consumption and
dietary omega-3 fatty acid supplements may help prevent heart disease
Literally
hundreds of clinical trials, including some that have gained widespread
attention, have been done on the possible benefits of omega-3 fatty acids for
the prevention of heart disease – producing conflicting results, varied claims,
and frustrated consumers unsure what to believe.
A
recent analysis done by scientists in the Linus Pauling Institute at Oregon
State University, published in the Journal
of Lipid Research, has sorted through many of these competing findings, and
it helps to explain why so many of the studies seem to arrive at differing
conclusions.
The
review concludes that both fish consumption and dietary omega-3 fatty acid
supplements may still help prevent heart disease; that some fatty acids, from
certain sources, are more effective than others; that these compounds may have
enormous value for serious health problems other than heart disease; and that
the very effectiveness of modern drug therapies for heart disease may be one
explanation for the conflicting findings on the benefits of omega-3 fatty
acids.
“After
decades of studying omega-3 fatty acids, it’s clear that they have value in
primary prevention of heart disease,” said Donald Jump, author of the analysis,
a principal investigator in the Linus Pauling Institute, and professor in the
OSU College of Public Health and Human Sciences.
“It’s
less clear how much impact fish oils have in preventing further cardiovascular
events in people who already have heart disease,” Jump said. “The studies done
several decades ago showed value even for that patient population, but the more
recent studies are less conclusive. We believe that one explanation is the
effectiveness of current state-of-the-art treatments now being offered.”
Some
of the earliest work that raised interest in omega-3 fatty acids was done in
the 1970s with Greenland Inuits, who ate large amounts of fish and were found
to have unusually low levels of cardiovascular disease. But, Jump said,
millions of people now at risk for cardiovascular disease take medications such
as statin drugs for high cholesterol; fibrates for high triglycerides; anti-thrombotics
to thin their blood; and other drugs with anti-inflammatory or anti-arrhythmia
effects.
Fish
oils can have positive effects on virtually all of these same cardiovascular
risk factors, Jump said, but so can the drugs.
“Some
of the early studies done on fish oil were prior to so many effective
medications being widely available and heavily used,” Jump said. “And people
often forget that nutrients, like fish oils, are less potent than prescription
drugs, and often have their best value when used for extended periods.
“When
so many people in these studies are taking a regimen of medications to address
the same issues that fish oil might also affect, it’s easy to understand why
any added benefit from the fish oils is more difficult to detect,” he said.
The
point, Jump said, is not that omega-3 fatty acids have no value – they do. But
for studies of their value in cardiovascular disease, which are often done when
patients are taking other medications, that value is less clear.
A
wide body of other research, he says, makes it clear that omega-3 fatty acids
also have health benefits that go beyond cardiovascular disease. They have been
shown to improve visual acuity; improve cognitive function and reduce dementia;
reduce inflammation and perhaps some types of cancer, such as colon cancer; and
reduce total mortality.
Among
the findings of this review:
-
An important type of omega-3 fatty acid for human health is DHA, which is the
predominant omega-3 fatty acid that accumulates in tissues.
-
Plant-derived sources of these fatty acids, such as flaxseed oil or chia seeds,
have less benefit than those from cold-water fish, because of differences in
how the human body processes these nutrients.
-
For individuals unwilling or unable to consume fish or fish-oil supplements,
some products made from yeast or algae are high quality.
-
It’s difficult to be certain of the amount of omega-3 fatty acids in
farm-raised fish, since these fish require dietary omega-3 supplementation.
“We
still believe the evidence is strong that the EPA and DHA content in heart
tissues and blood is important to health and to the prevention of
cardiovascular disease,” Jump said. “To meet the current recommendations for
primary prevention of cardiovascular disease, individuals are advised to
consume 200-300 milligrams of combined EPA and DHA per day.”
Mounting
evidence of fish oil's heart health benefits
There
is mounting evidence that omega-3 fatty acids from fish or fish oil supplements
not only help prevent cardiovascular diseases in healthy individuals, but also
reduce the incidence of cardiac events and mortality in patients with existing
heart disease. A new study, published in the August 11, 2009, issue of the Journal of the American College of
Cardiology, extensively reviews data from a broad range of studies in tens
of thousands of patients and sets forth suggested daily targets for omega-3
consumption.
"This
isn't just hype; we now have tremendous and compelling evidence from very large
studies, some dating back 20 and 30 years, that demonstrate the protective
benefits of omega-3 fish oil in multiple aspects of preventive
cardiology," said Carl Lavie, M.D., F.A.C.C., medical director of Cardiac
Rehabilitation and Prevention, Ochsner Medical Center, New Orleans, LA, and
lead author of the article. "The strongest evidence of a cardioprotective
effect of omega-3s appears in patients with established cardiovascular disease
and following a heart attack with up to a 30 percent reduction in CV-related
death."
Dietary
intake of fish oil can also decrease the risk of atherosclerosis, arrhythmias,
heart attack, sudden cardiac death and even health failure. Dr. Lavie adds that
although there is a smaller benefit in reducing heart failure death—9 percent
mortality benefit in a major recent randomized controlled trial—this is still
very impressive given patients' grave prognosis.
"If
we translate this finding, it means that we only need to treat 56 patients for
four years to prevent one death," he said. "And we are talking about
a very safe and relatively inexpensive therapy."
Most
of the evidence for the cardioprotective benefits supports the use of DHA
(docosahexaenoic acid) and EPA (eicosapentaenoic acid), the long-chain fatty
acids in the omega-3 family. According to Dr. Lavie, EPA and DHA work by
getting into the membranes of cells and, in doing so, may help to improve the
heart's electrical activity, vascular tone, plaque stabilization and blood
pressure, among other benefits. Studies show that the reduction in CV events is
inversely related to the tissue level EPA and, even more so, DHA.
Based
on these findings, and because the body does not produce its own essential
fatty acids, the authors recommend that healthy individuals should consume 500
mg daily of omega-3 fish oil containing EPA and DHA, and people with known
heart disease or heart failure aim for at least 800 to 1,000 mg daily.
"There
are clear health and heart benefits associated with increasing one's intake of
foods that are rich in Omega-3s, including oily fish like salmon, sardines,
trout, herring, and oysters" said Dr. Lavie "Patients should talk
with their doctors about whether a fish oil supplement is needed to get the
right amount and, in turn, benefit from the associated cardiovascular
protection."
Dr.
Lavie and his team came across only a few negative studies, including a recent
one that showed no benefit in post-MI patients, but it has raised the
possibility that omega-3 fatty acids may not provide as much additional
protective benefits in low-risk patients already receiving extensive and
rigorous post-MI therapies. "It was a one-year study that enrolled fewer
than 4,000 patients and the majority were using aspirin, clopidogrel, statins,
beta-blockers and ACE-inhibitors—the best of modern medicine," he said.
"It may be that their risk was so low to start, that a larger study with
longer follow-up would be required to better assess the true efficacy of omega-3
in such relatively low-risk patients."
Authors
say further studies are needed to investigate and determine optimal dosages, as
well as the relative ration of DHA and EPA that provides maximal heart
protection in those at risk of cardiovascular disease, and in the treatment of
atherosclerosis, arrhythmias and heart attacks.
Interestingly,
culture has historically played a role; sometimes dubbed the "Eskimo
factor," research shows cultures that have traditionally supported a diet
rich in fish oil (Asian and Alaskan American populations) had a lower
prevalence of cardiovascular disease and mortality, including a reduced
prevalence of atherosclerosis and heart disease, compared to European and
United States populations where consumption of fish is lower. Ironically, the
introduction of Western dietary practices into Asian and Native American
cultures may be diluting the cardioprotective benefits enjoyed by these
populations by both reducing the overall intake of fish oils, as well as
overwhelming its benefits with other deleterious dietary practices, including
high intakes of saturated and trans fats and cholesterol.
Fish consumption and
omega-3 fatty acid supplements may help prevent heart disease
Literally
hundreds of clinical trials, including some that have gained widespread
attention, have been done on the possible benefits of omega-3 fatty acids for
the prevention of heart disease – producing conflicting results, varied claims,
and frustrated consumers unsure what to believe.
A
recent analysis done by scientists in the Linus Pauling Institute at Oregon
State University, published in the Journal
of Lipid Research, (November, 2012) has sorted through many of these
competing findings, and it helps to explain why so many of the studies seem to
arrive at differing conclusions.
The
review concludes that both fish consumption and dietary omega-3 fatty acid
supplements may still help prevent heart disease; that some fatty acids, from
certain sources, are more effective than others; that these compounds may have
enormous value for serious health problems other than heart disease; and that
the very effectiveness of modern drug therapies for heart disease may be one
explanation for the conflicting findings on the benefits of omega-3 fatty
acids.
“After
decades of studying omega-3 fatty acids, it’s clear that they have value in
primary prevention of heart disease,” said Donald Jump, author of the analysis,
a principal investigator in the Linus Pauling Institute, and professor in the
OSU College of Public Health and Human Sciences.
“It’s
less clear how much impact fish oils have in preventing further cardiovascular
events in people who already have heart disease,” Jump said. “The studies done
several decades ago showed value even for that patient population, but the more
recent studies are less conclusive. We believe that one explanation is the
effectiveness of current state-of-the-art treatments now being offered.”
Some
of the earliest work that raised interest in omega-3 fatty acids was done in
the 1970s with Greenland Inuits, who ate large amounts of fish and were found
to have unusually low levels of cardiovascular disease. But, Jump said,
millions of people now at risk for cardiovascular disease take medications such
as statin drugs for high cholesterol; fibrates for high triglycerides;
anti-thrombotics to thin their blood; and other drugs with anti-inflammatory or
anti-arrhythmia effects.
Fish
oils can have positive effects on virtually all of these same cardiovascular
risk factors, Jump said, but so can the drugs.
“Some
of the early studies done on fish oil were prior to so many effective
medications being widely available and heavily used,” Jump said. “And people
often forget that nutrients, like fish oils, are less potent than prescription
drugs, and often have their best value when used for extended periods.
“When
so many people in these studies are taking a regimen of medications to address
the same issues that fish oil might also affect, it’s easy to understand why
any added benefit from the fish oils is more difficult to detect,” he said.
The
point, Jump said, is not that omega-3 fatty acids have no value – they do. But
for studies of their value in cardiovascular disease, which are often done when
patients are taking other medications, that value is less clear.
A
wide body of other research, he says, makes it clear that omega-3 fatty acids
also have health benefits that go beyond cardiovascular disease. They have been
shown to improve visual acuity; improve cognitive function and reduce dementia;
reduce inflammation and perhaps some types of cancer, such as colon cancer; and
reduce total mortality.
Among
the findings of this review:
-
An important type of omega-3 fatty acid for human health is DHA, which is the
predominant omega-3 fatty acid that accumulates in tissues.
-
Plant-derived sources of these fatty acids, such as flaxseed oil or chia seeds,
have less benefit than those from cold-water fish, because of differences in
how the human body processes these nutrients.
-
For individuals unwilling or unable to consume fish or fish-oil supplements,
some products made from yeast or algae are high quality.
-
It’s difficult to be certain of the amount of omega-3 fatty acids in
farm-raised fish, since these fish require dietary omega-3 supplementation.
“We
still believe the evidence is strong that the EPA and DHA content in heart
tissues and blood is important to health and to the prevention of
cardiovascular disease,” Jump said. “To meet the current recommendations for
primary prevention of cardiovascular disease, individuals are advised to
consume 200-300 milligrams of combined EPA and DHA per day.”
Couple of weekly portions of oily fish can help ward off stroke but fish oil supplements don't have the same effect
Eating
at least two servings of oily fish a week is moderately but significantly
associated with a reduced risk of stroke, finds a study published on bmj.com.
But
taking fish oil supplements doesn't seem to have the same effect, say the
researchers.
Regular
consumption of fish and long chain omega 3 fatty acids has been linked with a
reduced risk of coronary heart disease and current guidelines recommend eating
at least two portions of fish a week, preferably oily fish like mackerel and
sardines. But evidence supporting a similar benefit for stroke remains unclear.
So
an international team of researchers, led by Dr. Rajiv Chowdhury at Cambridge
University and Professor Oscar H. Franco at Erasmus MC Rotterdam, analysed the
results of 38 studies to help clarify the association between fish consumption
and risk of stroke or mini-stroke (transient ischaemic attack or TIA).
Collectively, these conditions are known as cerebrovascular disease.
The
38 studies involved nearly 800,000 individuals in 15 countries and included
patients with established cardiovascular disease (secondary prevention studies)
as well as lower risk people without the disease (primary prevention studies).
Differences in study quality were taken into account to identify and minimise
bias.
Fish
and long chain omega 3 fatty acid consumption was assessed using dietary
questionnaires, identifying markers of omega 3 fats in the blood, and recording
use of fish oil supplements. A total of 34,817 cerebrovascular events were
recorded during the studies.
After
adjusting for several risk factors, participants eating two to four servings a
week had a moderate but significant 6% lower risk of cerebrovascular disease
compared with those eating one or fewer servings of fish a week, while
participants eating five or more servings a week had a 12% lower risk.
An
increment of two servings per week of any fish was associated with a 4% reduced
risk of cerebrovascular disease. In contrast, levels of omega 3 fats in the
blood and fish oil supplements were not significantly associated with a reduced
risk.
Several
reasons could explain the beneficial impact of eating fish on vascular health,
say the authors. For example, it may be due to interactions between a wide
range of nutrients, like vitamins and essential amino acids, commonly found in
fish. Alternatively, eating more fish may lead to a reduction in other foods,
like red meat, that are detrimental to vascular health. Or higher fish intake
may simply be an indicator of a generally healthier diet or higher
socioeconomic status, both associated with better vascular health.
The
differences seen between white and oily fish may be explained by the way they
are typically cooked (white fish is generally battered and deep fried, adding
potentially damaging fats).
Although
there's a possibility that some other unmeasured (confounding) factor may
explain their results, the authors conclude that "they reinforce a
potentially modest beneficial role of fish intake in the cause of
cerebrovascular disease."
In
addition, they say their findings are in line with current dietary guidelines
that encourage fish consumption for all; and intake of fish oils to people with
pre-existing or at high risk of heart disease. They also support the view that
future nutritional guidelines should be principally "food based."
In
an accompanying editorial, authors from the Division of Human Nutrition at
Wageningen University suggest that although it is "reasonable" to
advise patients that eating one or two portions of fish per week could reduce
the risk of coronary heart disease and stroke, any benefit of long chain omega
3 fatty acid supplementation is likely to be small. They say it is possible,
however, that patients with additional risk factors such as diabetes may
benefit.
Heart Failure Risk Lower
in Women Who Often Eat Baked/Broiled Fish
The
risk of developing heart failure was lower for postmenopausal women who
frequently ate baked or broiled fish, but higher for those who ate more fried
fish, in a study reported May 2011 in Circulation:
Heart Failure, an American Heart Association journal.
In
a large-scale analysis, women who ate the most baked/broiled fish (five or more
servings/week) had a 30 percent lower risk of heart failure compared to women
who seldom ate it (less than one serving/month).
Previous
research has found that fatty acids (omega-3) in fish -- EPA, DHA and ALA --
may lower risk of cardiovascular disease by decreasing inflammation, resisting
oxidative stress and improving blood pressure, cardiac and blood vessel
function.
This
study showed that they type of fish and cooking method may affect heart failure
risk. The researchers found that dark fish (salmon, mackerel and bluefish) were
associated with a significantly greater risk reduction than either tuna or
white fish (sole, snapper and cod).
In
a similar analysis, eating fried fish was associated with increased heart
failure risk. Even one serving a week was associated with a 48 percent higher
heart failure risk.
"Not
all fish are equal, and how you prepare it really matters," said Donald
Lloyd-Jones, M.D., Sc.M., senior author of the study. "When you fry fish,
you not only lose a lot of the benefits, you likely add some things related to
the cooking process that are harmful."
Other
research has shown that frying increases the trans fatty acid (TFA) content of
foods, which is associated with increasing risk for heart disease. In this
study, however, the researchers did not find an association between TFA and
heart failure risk.
Lloyd-Jones
and his team examined self-reported dietary data from 84,493 postmenopausal
women in the Women's Health Initiative Observational Study. They then divided
study participants based on the frequency and type of fish consumption. Two
groups of fish intake were defined: baked/broiled fish or fried fish. The
baked/broiled fish group consisted of canned tuna, tuna salad, tuna casserole,
white fish (broiled or baked), dark fish (broiled or baked) and shellfish (not
fried). The fried fish group consisted of fried fish, fish sandwich and fried
shellfish.
They
conducted their analysis based on data from 1991 through August 2008. During an
average follow-up of 10 years, 1,858 cases of heart failure occurred.
Most
participants (85 percent) were Caucasian, 7 percent African-American and 3
percent Hispanic. Their average age was 63 at baseline.
Participants
whose diets included more baked/broiled fish tended to be healthier and younger
than their counterparts who ate fried fish. They were more physically active
and fit, more educated and less likely to smoke, have diabetes, high blood
pressure and heart disease (irregular heartbeat and coronary artery disease).
Furthermore, their diets contained more fruits and vegetables, less unhealthy,
saturated and trans fatty acids and more beneficial fatty acids, which are
found in fish and in non-marine foods such as nuts, seeds and certain vegetable
oils. Consumption of fried fish was associated with higher body mass index (a
weight-to-height ratio), higher energy intakes (calories) and lower fiber
consumption. Consumption of other fried foods besides fish was adjusted in the
analysis.
While
previous studies have linked omega-3 fatty acids to a decrease in some types of
heart disease, their precise relationship to heart failure risk was unclear.
Researchers sought to clarify the connection between fish and heart failure
risk in postmenopausal women.
"Baking
or broiling fish and eating it frequently seem to be part of a dietary pattern
that is very beneficial for a number of things," said Lloyd-Jones,
associate professor, preventive cardiologist and chair of the Department of
Preventive Medicine at Northwestern University Feinberg School of Medicine in
Chicago. "In this case, we demonstrated that it's associated with heart
failure prevention. This suggests that fish is a very good source of lean
protein that we ought to be increasing as a proportion of our diet and
decreasing foods that contain less healthy saturated and trans fats."
The
results of this study are consistent with previous findings in studies of older
American and Swedish populations, he said, "but the new study adds the
interesting results on darker fish. They also suggest that baked/broiled fish
is associated with reduced risk of heart failure through mechanisms other than
reducing risk for a heart attack, a precursor to heart failure in some
people."
In
the United States, heart failure affects about 5.7 million people. Although the
heart continues to function in this disease, it's unable to pump blood
efficiently enough to meet the body's needs. Heart failure has many different
causes, including smoking, high blood pressure, diabetes, overweight, lack of
physical activity and poor diet. It's often treatable with lifestyle changes,
medicine or surgery.
Moderate
Fish Consumption May Lower Heart Disease Risk
Including
fish in a balanced diet has long been associated with the prevention of heart
disease, and scientists now believe that it can help preserve heart function in
patients who have experienced heart failure. A new study in the Journal of Food Science (December, 2009)
reports that moderate fish consumption can help reduce the risk of left
ventricular systolic dysfunction (LVSD) in post acute coronary syndrome (ACS)
patients.
Researchers
from the University of Athens in Greece focused on demographical, nutritional,
lifestyle, and medical factors combined with the risk of developing left
ventricular dysfunction after nonfatal heart failure. The study included nearly
one thousand patients who were hospitalized after ACS.
At
the study’s conclusion, researchers noted that consuming fish one to two times
per week was independently associated with a considerable reduction of the odds
of developing LVSD. However, a higher consumption of fish did not result in
further protection from the occurrence of LVSD.
Fish Oil May Protect Against Stroke
Research
led by Hernan A. Bazan, MD, Assistant Professor of Surgery, Section of Vascular
Surgery, at LSU Health Sciences Center New Orleans School of Medicine, has
found that unstable carotid artery plaques - those in danger of rupturing and
leading to a stroke - contain more inflammation and significantly less omega-3
fatty acids than asymptomatic plaques. This suggests that increasing the levels
of omega-3 fatty acids in carotid artery plaques could either prevent strokes
or improve the safety of treatment. This may be accomplished by increasing
dietary intake of foods rich in omega-3 fatty acids. The study is in the
journal, Vascular Pharmacology.
Our
bodies produce only a small amount of omega-3 fatty acids, so most of what we
need has to come from eating omega-3 fatty acid-rich foods like fish (salmon,
tuna, trout, herring, etc.) or from supplements. Omega-3 fatty acids have been
shown to protect against cardiovascular disease, particularly heart attack and
sudden cardiac death. Dr. Bazan's team wanted to determine what the association
might be with plaques in the carotid arteries, a common cause of strokes.
Vulnerable plaques which can rupture in the carotid arteries may lead to
transient ischemic attacks (TIAs), strokes, or vision loss by affecting the
artery to the retina. The mechanisms leading to plaque rupture are still not
fully understood but inflammation within the plaque is beginning to be
recognized as an important cause of plaque rupture.
Dr.
Bazan, an LSUHSC vascular/endovascular surgeon, in collaboration with
researchers at Yale University and others at LSUHSC, analyzed plaques from 41
patients who underwent carotid endarterectomy (CEA) to remove plaque buildup in
their arteries. Twenty-four patients were asymptomatic and 17 were symptomatic,
having had neurological symptoms. All of the fats in the plaques were assessed
with mass spectrometry, in collaboration with Dr. Song Hong at LSUHSC. The team
was measuring the amounts of docosahexaenoic acid (DHA) and eicosapentaenoic
acid (EPA) - the components of long-chain omega-3 polyunsaturated fatty acids.
The plaques of asymptomatic patients contained more than twice as much DHA as
the symptomatic patients, and about one and a half times as much EPA.
Significantly less inflammation was also seen in the carotid atherosclerotic
plaques from asymptomatic patients.
"In
the future, a study to address whether supplementation with dietary omega-3
polyunsaturated fatty acids prevents carotid-related events in patients with
moderate or high-grade carotid stenosis will help answer whether this is a
formidable therapeutic target for the prevention of stroke," says Dr.
Bazan.
According
to the Centers for Disease Control and Prevention, stroke is the third leading
cause of death in the United States, as well as a leading cause of serious
long-term disability. About 795,000 strokes occur in the US each year and about
610,000 of these are first, or new, strokes. About 185,000 occur in people who
have already had a stroke. Nearly 25 percent of strokes occur in people under
the age of 65. Of all ischemic strokes occurring, carotid artery
atherosclerotic plaques account for over a third of them. It has been noted for
several decades that the southeastern United States has the highest stroke
mortality in the country. It is not completely clear what factors might
contribute to the higher incidence and mortality from stroke in this region.
Fish: Research Shows Novel Benefits of Fatty Acids in Arteries
New
research from Columbia University Medical Center continues to shed light on the
benefits of making fish a staple of any diet.
Fish
are generally rich in omega-3 fatty acids, which have shown benefit in many
health areas such as helping to prevent mental illness and delaying some of the
disabilities associated with aging. Eating tuna, sardines, salmon and other
so-called cold water fish appears to protect people against clogged arteries.
Omega-3 fatty acids can also lower triglycerides, a type of fat often found in
the bloodstream.
Now,
a CUMC research team led by Richard J. Deckelbaum, M.D., Director of the
Columbia Institute of Human Nutrition, has found that a diet rich in fish oils
can prevent the accumulation of fat in the aorta, the main artery leaving the
heart. The beneficial actions of fish oil that block cholesterol buildup in
arteries are even found at high fat intakes.
The
study was conducted in three separate populations of mice: one that was fed a
balanced diet, one that was fed a diet resembling a “Western” diet high in
saturated fat, and a third that was fed a high fish fat diet rich in omega-3
fatty acids.
Researchers
in Dr. Deckelbaum’s laboratory, including Chuchun Liz Chang, a Ph.D. student in
nutritional and metabolic biology, found that the fatty acids contained in fish
oil markedly inhibit the entry of “bad,” or LDL, cholesterol into arteries and,
as a result, much less cholesterol collects in these vessels.
They
found that this is related to the ability of those fatty acids to markedly
decrease lipoprotein lipase, a molecule that traps LDL in the arterial wall.
This will likely prove to be important as a new mechanism which helps explain
benefits of omega-3 fatty acids on heart health.
Dr.
Deckelbaum advises those interested in increasing omega-3 intakes do so by
either increasing fish intake or by using supplements that contain the
“long-chain” fatty acids, EPA and DHA, which are found in cold water fish.
The
research was published February 5, 2009 by the American Heart Association’s Arteriolosclerosis, Thrombosis and Vascular
Biology, and is supported in part by grants from the National Institutes of
Health.
Eating fish may explain very low levels of heart disease in Japan
Consuming
large quantities of fish loaded with omega-3 fatty acids may explain low levels
of heart disease in Japan, according to a study led by the University of
Pittsburgh Graduate School of Public Health slated for the Aug. 5, 2008 issue
of the Journal of the American College of
Cardiology and available online. The study also found that third- and
fourth-generation Japanese Americans had similar or even higher levels of
atherosclerosis, or hardening of the arteries – a major risk factor for heart
disease, compared to white Americans.
The
very low rate of heart disease in Japan among developed countries has been
puzzling. Death rates from coronary heart disease in Japan have been less than
half of that in the U.S. This holds true even among Japanese men born after
World War II who adopted a Western lifestyle since childhood, and despite the
fact that among these same men, risk factors for coronary heart disease (serum
levels of total cholesterol, blood pressure and rates of type 2 diabetes) are
very similar among men in the U.S. Additionally, the rate of cigarette smoking,
another major risk factor, has been infamously high in Japan.
"Our
study suggests that very high levels of omega-3 fatty acids have strong
properties that may help prevent the buildup of cholesterol in the
arteries," said Akira Sekikawa, M.D., Ph.D., study lead author and
assistant professor of epidemiology at the University of Pittsburgh Graduate
School of Public Health. "Increasing fish intake to two times a week for
healthy people is currently recommended in the U.S. Our study shows much higher
intake of fish observed in the Japanese may have strong anti-atherogenic
effect."
Fish
consumption among the Japanese is one of the highest in the world. Japanese men
consume an average of 100 grams, equivalent to about 3.75 ounces, of fish every
day from early in life. Meanwhile, Americans typically eat fish less than two
times a week.
"The
Japanese eat a very high level of fish compared to other developed
countries," said Dr. Sekikawa. "While we don't recommend Americans
change their diets to eat fish at these quantities because of concerns about
mercury levels in some fish, increasing intake of omega-3 fatty acids in the
U.S. could have a very substantial impact on heart disease. Given the similar
levels of atherosclerosis in Japanese Americans and white Americans, it also tells
us that lower levels of heart disease among Japanese men are much more likely
lifestyle related than a result of genetic differences," said Dr.
Sekikawa.
Omega-3
fatty acids are a type of polyunsaturated fat found primarily in fish. The two
most potent omega-3 fatty acids are known as docosahexaenoic acid (DHA) and
eicosapentaenoic acid (EPA) and are usually found in oily fishes, such as
mackerel, salmon and tuna.
Taking Fish Oil Supplements
Do
fish oil supplements just seem too … well … fishy?
The
Mayo Clinic Health Letter explains some health benefits of this diet supplement
and ways to overcome the occasional fishy aftertaste.
Fish
oil supplements are especially good for those who want the heart health
benefits of omega-3 fatty acids but don’t like to eat fish. Fish oil
supplements often are prescribed for heart attack survivors; the supplements
can help prevent future heart problems. They also are prescribed for people
with high triglycerides, a type of fat in the blood.
Tips
to avoid fishy aftertaste or burps include:
--
Swallow the capsule frozen. This slows the breakdown of fish oil in the
stomach, often reducing fishy burps. The fish oil is still digested
effectively.
--
Take the capsule at the beginning of a meal. Food traps the fish oil in the
stomach, and mixing buffers the odor.
Try
an “odorless” supplement. This type of coated capsule passes through the
stomach and dissolves in the intestines.
Switch
brands. A different brand may taste less fishy. For fish oil purists, some
manufacturers make a pure omega-3 fatty acids product that doesn’t taste fishy,
although it is likely to cost more than standard products.
Fried Fish Fuels Strokes
Eating
a Southern staple, fried fish, could be one reason people in Alabama and across
the "stroke belt" states are more likely than other Americans to die
of a stroke, according to a study published in the December 22, 2010, online
issue of Neurology, the medical
journal of the American Academy of Neurology (AAN).
In
the stroke belt states – Alabama, Arkansas, Georgia, Louisiana, Mississippi,
North Carolina, South Carolina and Tennessee – the risk of dying from stroke is
higher than in other parts of the country. In Alabama, the stroke death rate is
125 per every 100,000 people, against a national average of just 98 per
100,000.
The
study was part of the long-running REGARDS (Reasons for Geographic And Racial
Differences in Stroke) trial, led by George Howard, Dr. PH, at the University
of Alabama at Birmingham. REGARDS enrolled 21,675 people over the age of 45
between January 2003 and October 2007, and continues to follow them for health
events.
Studies
have shown that the omega-3 fatty acids in fish, especially fatty fish, may
reduce the risk of stroke, but other research has shown that frying fish leads
to the loss of the natural fatty acids, the AAN said in a press release.
The
American Heart Association recommends that people eat fish at least twice a
week, with an emphasis on fatty fish. In the entire study, fewer than 1 in 4
participants consumed two or more servings of non-fried fish per week; people
in the stroke buckle were 17 percent less likely to meet the recommendations
than those in the rest of the country, the AAN said.
Moreover,
the study showed that people in the stroke belt were 30 percent more likely to
eat two or more servings of fried fish than those in the rest of the country.
"These
differences in fish consumption may be one of the potential reasons for the
racial and geographic differences in stroke incidence and mortality," Fadi
Nahab, M.D., of Emory University, author of the current paper, said in an AAN
press release.
"Our
study showed that stroke belt residents, especially African-Americans, eat more
fried fish than Caucasians and people living in the rest of the country,"
said Howard, professor and chair of the Department of Biostatistics in the
School of Public Health at UAB.
The
study found that blacks were more than three and a half times more likely to
eat fried fish per week than whites, with an overall average of about one
serving per week of fried fish for blacks compared to half of a serving for
whites.
"One
of the next steps in this research will be to determine if people who eat
higher amounts of non-fried fish have less risk of stroke than people who don't
eat a lot of fish or eat more fried fish," says Suzanne Judd, Ph.D.,
assistant professor of biostatistics at UAB and a study co-author.
Omega-3
fatty acids appear to protect damaged heart after heart attack
Taking omega-3 fatty acids appeared to lower inflammation
and guard against further declines in heart function among recent heart attack
survivors already receiving optimal standard care, according to results from a
randomized, controlled trial to be presented at the American College of
Cardiology's 64th Annual Scientific Session in San Diego.
Patients in the study taking 4 grams of prescription-only
omega-3 fatty acid capsules daily for six months after a heart attack were
significantly more likely to show improvements in heart function compared to
patients taking a placebo. Heart function was measured by an expansion of the
left ventricular endsystolic volume index. Patients taking omega-3 fatty acids
also had significantly less evidence of fibrosis -- a thickening or scarring of
the areas of the heart remote from the heart attack, which can develop when the
surviving heart muscle works harder and under high pressure to compensate for
the damage to the heart. The data suggests that patients who were able to mount
a substantial change in levels of omega-3 fatty acids in their blood derived
the most benefit.
"Giving a high dose of omega-3 fatty acids soon after
a heart attack appears to improve cardiac structure and heart functioning above
and beyond the standard of care," said Raymond W. Kwong, M.D., M.P.H,
director of cardiac magnetic resonance imaging at Brigham and Women's Hospital
in Boston and the study's senior author. "Because this is a unique group
of patients with remarkably high adherence to [guideline-directed] treatments
for acute myocardial infarction already, we feel fairly confident that the
benefits from this therapy are additive. The implications of this study could
be fairly large."
An estimated 720,000 Americans have heart attacks each
year. After a heart attack, the heart can remodel or reorganize itself to
maintain or improve function. In some cases, the heart may undergo adverse
changes such as enlargement of the heart, decreased pumping ability or added
cardiac strain that can predispose someone to heart failure and arrhythmias
later in life.
Although earlier studies have shown that omega-3 fatty
acids may lower the risk of irregular heartbeats and death from a heart attack,
research has not consistently shown a benefit. Kwong said his research is the
first to use quantitative cardiac imaging to look at how omega-3 fatty acids
might actually protect the heart after a major heart attack.
Researchers randomized 374 patients recovering from a
heart attack and receiving standard treatment to take either 4 grams of omega-3
fatty acids or a placebo; groups were balanced in terms of location of the
infarct--anterior or non-anterior--and age. Blood work and cardiac imaging were
analyzed at two to four weeks post-heart attack and again at six months.
Compared to previous research, this study used a much higher dose of omega-3
fatty acids, 4 grams compared to 1 gram daily, and a small amount of corn oil,
which does not contain fatty acids, as the placebo.
By using cardiac magnetic resonance imaging, researchers
were able to look at changes in patients' hearts and see the disease process
before and after treatment. Adverse changes in left ventricular remodeling and
function, in addition to the worsening of fibrosis, were used as surrogates for
poor outcomes after heart attack.
Patients taking the omega-3 fatty acids were 39 percent
less likely to show a deterioration of heart function as compared to patients taking
a placebo. The analysis also looked at key markers of systemic inflammation,
which were also more likely to be improved in those taking the fish oil. In
particular, the percent reduction in ST2, a marker of the severity of adverse
cardiac remodeling and tissue fibrosis, was substantially greater in the
treatment arm after six months.
"Omega-3 fatty acids may have anti-inflammatory
effects and also promote better cardiac healing," Kwong said. "This
is important because other anti-inflammatory agents, including steroids and
NSAIDS, have failed to make a difference after myocardial infarction."
Patients in the study who had a 5 percent increase in the amount of omega-3
fatty acid in their blood seem to have the best chance of improving heart function.
"If this becomes a useful therapy, it seems a 5
percent increase in the serum level of omega-3 fatty acids correlates with a 10
percent improvement in left ventricular remodeling," he said. In this
study, most (92 percent) of patients randomized to fish oil increased omega-3
fatty acid by at least 5 percent, compared with less than half (42 percent) of
patients receiving placebo.
Kwong said the higher-dose omega-3 fatty acids was not
found to be associated with any major safety issues, such as increased
bleeding. "It's a very well-tolerated therapy," he said, adding that
it is unlikely patients could get the amount of omega-3 fatty acids from diet
alone. He said the daily 4 gram dose is roughly equivalent to someone eating a
large, 8-ounce serving of salmon every day for six months.
For many years, the American College of Cardiology and the
American Heart Association have recommended that people eat fish rich in
omega-3 fatty acids at least twice a week because of its potential heart
benefits.
Kwong said most North Americans do not follow this advice,
while Japanese populations with higher levels of omega-3 and an otherwise
similar risk profile to North Americans have lower risks of heart disease and
sudden cardiac death. The increase in the omega-3 blood content of many
patients in Kwong's study at six months was similar to levels found in Japanese
populations with a diet very rich in omega-3 fatty acids.
No comments:
Post a Comment